Overview
- 102 inspections across 98 sites are on record.
- 161 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-08.
At a glance
Inspections
102
Sites
98
Observations
161
Career since
Mar 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Vitalife Laboratories (A Div. Of Arch Pharmalabs Limited) | 8 May 2026 | Human Drugs | On file |
| Axxelent Pharma Science Private Limited | 17 Apr 2026 | Human Drugs | On file |
| Aarti Pharmalabs Limited | 27 Mar 2026 | Human Drugs | On file |
| Lupin Limited | 7 Mar 2026 | Human Drugs | On file |
| PETNET Solutions, Inc. | 3 Feb 2026 | Human Drugs | On file |
Sites inspected
Vitalife Laboratories (A Div. Of Arch Pharmalabs Limited)Gurugram, India1 insp.
Axxelent Pharma Science Private LimitedSri City, Tirupati, India1 insp.
Aarti Pharmalabs LimitedPalghar, India1 insp.
Lupin LimitedAnkleshwar, India1 insp.
PETNET Solutions, Inc.Cincinnati, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Craig T Rybus4 shared
Karen M Cooper4 shared
Anna M Spiros2 shared
Travis V Hull2 shared
Jacob G Lutz2 shared
Michele L Glendenning2 shared
Andrew J Barrowcliff2 shared
Cheryl A Grandinetti2 shared
Yvette M Lacour-Davis2 shared
Marcia A Worley2 shared
Full investigator report
Get the verbatim findings behind Geoffrey K Kilili's 161 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site